Source:http://linkedlifedata.com/resource/pubmed/id/20969937
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015237,
umls-concept:C0017066,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0021826,
umls-concept:C0021853,
umls-concept:C0031001,
umls-concept:C0184511,
umls-concept:C0242643,
umls-concept:C0444498,
umls-concept:C0699819,
umls-concept:C1516048,
umls-concept:C1533691,
umls-concept:C2349975
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-12-14
|
pubmed:abstractText |
In rats we examined the effects of some common excipients on the intestinal absorption of ganciclovir (GCV), a BCS-III drug and substrate of P-gp, by assessing its in vitro transfer from mucosa to serosa and in situ transepithelial permeation. In vitro, all selected excipients (concentration range 0.1-1% [w/v]) could increase the transport amount of GCV in the everted gut sac model. Whereas enhancement by F-68 demonstrated regional differences like verapamil, PEG-400, Tween-80 and EL-35 exhibited no regional differences. In situ studies were performed by an improved perfusion model, single-pass perfusion with whole small intestine, to determine more accurately the permeability of lipophobic compounds. The permeability of GCV was significantly increased by all excipients. The effects of EL-35 and F-68 were dose-dependent but those of PEG-400 and Tween-80 were not. The results suggest that enhancements of intestinal absorption of GCV by these excipients are probably due to inhibition of P-gp-mediated drug efflux. It could be deduced from their different properties that both blocking binding sites of P-gp and altering membrane fluidity were involved in their P-gp-inhibition. The former mechanism might be involved for F-68, while the latter one might account for the effects of PEG-400, Tween-80 and EL-35.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Excipients,
http://linkedlifedata.com/resource/pubmed/chemical/Ganciclovir,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1873-3476
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
17
|
pubmed:volume |
403
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-45
|
pubmed:meshHeading |
pubmed-meshheading:20969937-Animals,
pubmed-meshheading:20969937-Antiviral Agents,
pubmed-meshheading:20969937-Biological Transport,
pubmed-meshheading:20969937-Chromatography, High Pressure Liquid,
pubmed-meshheading:20969937-Epithelium,
pubmed-meshheading:20969937-Excipients,
pubmed-meshheading:20969937-Ganciclovir,
pubmed-meshheading:20969937-Glucose,
pubmed-meshheading:20969937-Intestinal Absorption,
pubmed-meshheading:20969937-Intestine, Small,
pubmed-meshheading:20969937-Male,
pubmed-meshheading:20969937-Models, Biological,
pubmed-meshheading:20969937-P-Glycoprotein,
pubmed-meshheading:20969937-Perfusion,
pubmed-meshheading:20969937-Rats,
pubmed-meshheading:20969937-Rats, Sprague-Dawley,
pubmed-meshheading:20969937-Substrate Specificity
|
pubmed:year |
2011
|
pubmed:articleTitle |
Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
|
pubmed:affiliation |
Huazhong University of Science and Technology, Wuhan, Hubei 430030, People's Republic of China.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|